Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05594043
What this trial is testing

MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001)

Who this might be right for
Advanced or Metastatic Solid Tumors
Merck Sharp & Dohme LLC 39
Testing effectiveness (Phase 2)Looking for participantsNCT06261125
What this trial is testing

Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)

Who this might be right for
Hepatocellular Carcinoma
Mian XI 60
Testing effectiveness (Phase 2)WithdrawnNCT06557278
What this trial is testing

Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Mirror Biologics, Inc.
Testing effectiveness (Phase 2)Study completedNCT02733042
What this trial is testing

Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LymphomaLeukemia, Lymphocytic, Chronic, B-Cell
Celgene 106
Testing effectiveness (Phase 2)Study completedNCT04636762
What this trial is testing

Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Second Xiangya Hospital of Central South University 40
Testing effectiveness (Phase 2)Study completedNCT02314481
What this trial is testing

Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity

Who this might be right for
Non-small Cell Lung Cancer
University College, London 50
Testing effectiveness (Phase 2)Study completedNCT02951767
What this trial is testing

Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)

Who this might be right for
Bladder Cancer
Hoffmann-La Roche 119
Testing effectiveness (Phase 2)Active Not RecruitingNCT03742102
What this trial is testing

Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
AstraZeneca 243
Testing effectiveness (Phase 2)Ended earlyNCT03968419
What this trial is testing

This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 88
Early research (Phase 1)Looking for participantsNCT05410717
What this trial is testing

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
Stage IV Ovarian CancerTestis Cancer, RefractoryEndometrial Cancer Recurrent+1 more
Second Affiliated Hospital of Guangzhou Medical University 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04067037
What this trial is testing

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Henan Cancer Hospital 60
Testing effectiveness (Phase 2)Temporarily pausedNCT05642195
What this trial is testing

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerNon-Small Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung+1 more
National Cancer Institute (NCI) 30
Not applicableUnknownNCT05278195
What this trial is testing

Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 300
Early research (Phase 1)Ended earlyNCT03752177
What this trial is testing

LY3415244 in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Eli Lilly and Company 12
Testing effectiveness (Phase 2)Looking for participantsNCT04951947
What this trial is testing

JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Hunan Province Tumor Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT03952065
What this trial is testing

IT or IA Infusion of PD1/PDL1/CTLA4 Inhibitors Versus IV for Immunotherapy of Head/Neck Cancers (HNC)

Who this might be right for
Head/Neck Neoplasm
Second Affiliated Hospital of Guangzhou Medical University 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07589049
What this trial is testing

Becotatug Vedotin Combined With Pucotenlimab as Neoadjuvant Therapy for Resectable Recurrent Head and Neck Squamous Cell Carcinoma After Progression on Immunotherapy: A Prospective Phase II Study

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT06449209
What this trial is testing

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

Who this might be right for
Extensive-stage Small-cell Lung CancerSmall-cell Lung Cancer
BioNTech SE 110
Testing effectiveness (Phase 2)Looking for participantsNCT05944237
What this trial is testing

HTL0039732 in Participants With Advanced Solid Tumours

Who this might be right for
NeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11 more
Cancer Research UK 150
Not applicableNot Yet RecruitingNCT06945601
What this trial is testing

The Effect of Previous Pregnancies in Patients With Gynecological Neoplasms Treated With PD-1/PD-L1 Inhibitors

Who this might be right for
Gynecologic Cancers
IRCCS San Raffaele 150
Next Page